Benitec Biopharma (BNTC) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for Benitec Biopharma (BNTC) over the last 5 years, with Q2 2025 value amounting to -$0.21.
- Benitec Biopharma's EPS (Weighted Average and Diluted) fell 9090.91% to -$0.21 in Q2 2025 from the same period last year, while for Jun 2025 it was -$1.03, marking a year-over-year increase of 8291.87%. This contributed to the annual value of -$1.05 for FY2025, which is 1393.44% up from last year.
- Latest data reveals that Benitec Biopharma reported EPS (Weighted Average and Diluted) of -$0.21 as of Q2 2025, which was down 9090.91% from -$0.38 recorded in Q1 2025.
- Benitec Biopharma's 5-year EPS (Weighted Average and Diluted) high stood at -$0.11 for Q2 2024, and its period low was -$9.88 during Q2 2022.
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.62 (2021), whereas its average is -$2.12.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first crashed by 118709.68% in 2022, then surged by 9584.91% in 2024.
- Quarter analysis of 5 years shows Benitec Biopharma's EPS (Weighted Average and Diluted) stood at -$0.59 in 2021, then plummeted by 466.1% to -$3.34 in 2022, then grew by 20.96% to -$2.64 in 2023, then skyrocketed by 90.15% to -$0.26 in 2024, then rose by 19.23% to -$0.21 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.21 in Q2 2025, compared to -$0.38 in Q1 2025 and -$0.26 in Q4 2024.